Drug Controller General of India

- Read more about DCGI granted siRNA Drug Trial
Biocon and its partner, Quark Pharmaceuticals, have received approval from the Drug Controller General of India (DCGI) to proceed with the study, the first ever clinical trial of a siRNA therapy in India.

RECOMMENDED POSTS

Aurobindo Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in QA, QC, Production, Packing

Opportunity for B.Pharm, Pharm.D at Government of India Enterprise HLL Lifecare | 20 Openings

Hiring Pharmacist at District Urban Health Unit

Interview for Pharmacist at Regional Institute of Education

NHSRC Hiring Quality & Patient Safety Consultant - B.Pharm Apply | Salary upto Rs. 1,20,000 month

Career for M.Pharm in Corporate Research & Development Division, HLL Lifecare | Salary Rs. 67,200 month